Last week, BA.2 represented about 35 percent of cases genetically analyzed in the U.S. according to the Centers for Disease Control and Prevention.
Last week, BA.2 represented about 35 percent of cases genetically analyzed in the U.S. according to the Centers for Disease Control and Prevention.